Form 4: Capital One CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Capital One's Chairman and CEO, Richard D. Fairbank, executed planned sales of common stock totaling 103,586 shares on October 27, 2025, following the exercise of stock options.
Summary
- Richard D. Fairbank, Chairman and CEO of Capital One Financial Corp (COF), engaged in transactions on October 27, 2025.
- He acquired 53,486 shares of common stock by exercising stock options at a price of $63.73 per share.
- Concurrently, he disposed of a total of 103,586 shares of common stock through multiple sales transactions.
- The sales occurred at weighted average prices ranging from $224.53 to $227.42 per share.
- These transactions were executed under a Rule 10b5-1 trading plan established on May 13, 2025.
- Following these transactions, Fairbank's direct beneficial ownership of Capital One common stock decreased to 4,051,228 shares.
- The reported beneficial ownership also includes shares acquired through the Company's Dividend Reinvestment Plan since the last reported transaction.
Sentiment
Score: 6
Explanation: While insider selling can sometimes be viewed negatively, the fact that these transactions were executed under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling. The CEO also retains a substantial stake in the company.
Positives
- Transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and not reactive sale.
- The CEO retains a substantial beneficial ownership of 4,051,228 shares, demonstrating continued alignment with shareholder interests.
Negatives
- The CEO sold a significant number of shares (103,586), which could be interpreted negatively by some investors, despite being pre-planned.
Future Outlook
NA
Industry Context
This is an insider transaction report, which is specific to the company and its executive compensation structure, rather than broader industry trends. It reflects a planned liquidity event for the CEO.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The reporting person entered into a Rule 10b5-1 trading plan on May 13, 2025, to manage the sale of equity securities. | 05/13/2025 | Enhances transparency and provides an affirmative defense against insider trading allegations for planned transactions. |
Stakeholder Impact
- Shareholders: The sale of shares by the CEO could be perceived as a slight negative, but the 10b5-1 plan context reduces this concern. The CEO's continued significant ownership stake maintains alignment.
Key Dates
| Date | Description |
|---|---|
| 02/15/2019 | Stock options became exercisable. |
| 05/13/2025 | Date Rule 10b5-1 trading plan was entered into. |
| 10/27/2025 | Date of stock option exercise and common stock sales. |
| 10/29/2025 | Signature date of the filing. |
| 02/03/2026 | Stock options expiration date. |
Recommendation
holdThis Form 4 filing details routine, pre-planned insider transactions by the CEO, including the exercise of stock options and subsequent sales, all under a Rule 10b5-1 plan. While a significant number of shares were sold, the planned nature of these transactions typically means they are not indicative of a change in management's outlook on the company's future performance. The CEO retains a substantial ownership stake. Therefore, this filing alone does not provide sufficient new information to warrant a change in investment recommendation; a 'hold' stance is appropriate, pending further fundamental analysis.
Keywords
Capital One, COF, Richard Fairbank, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, Share Sale, CEO, Financial Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.